Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
December 2028 250
2028-12-01
2028-12-01
2028-12-01
Study completion rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07606807
2028-12-01
Primary completion rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07606807
2028-12-01
Study completion Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07756398
2028-12-01
Primary completion Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07846579
2028-12-01
Study completion Single-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07934563
2028-12-01
Primary completion Single-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07934563
2028-12
2028-12
2028-12
2028-12
Primary completion Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02323581
2028-12
2028-12
Study completion Epinephrine Dose: Optimal Versus Standard Evaluation Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03826524
2028-12
Primary completion Epinephrine Dose: Optimal Versus Standard Evaluation Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03826524
2028-12
2028-12
2028-12
Study completion BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04666454
2028-12
Primary completion BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04666454
2028-12
Study completion MLC1501 Study Assessing Efficacy in STROke Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05046106
2028-12
Study completion Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05105321
2028-12
Study completion MYTHS - MYocarditis THerapy With Steroids Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05150704
2028-12
Study completion Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05262803
2028-12
Primary completion Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05262803
2028-12
2028-12
2028-12
2028-12
2028-12
2028-12
Study completion Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05627375
2028-12
2028-12
Study completion Anticoagulation in Post MI LV Thrombus Trial in Nepal Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05794399
2028-12
Primary completion Anticoagulation in Post MI LV Thrombus Trial in Nepal Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05794399
2028-12
Study completion First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05939076
2028-12
Study completion Strategy for Improving Stroke Treatment Response Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05948566
2028-12
2028-12
Primary completion First Responder Airway & Compression Rate Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05969028
2028-12
2028-12
2028-12
2028-12
2028-12
Study completion Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06310031
2028-12
Study completion Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06486012
2028-12
Study completion MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06543082
2028-12
Primary completion MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06543082
2028-12
Primary completion ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06716021
2028-12
2028-12
2028-12
Study completion Alleviant ALLAY-HFrEF Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06812533
2028-12
Primary completion Alleviant ALLAY-HFrEF Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06812533
2028-12
Study completion Safety of Short-course of NSAIDs in Pediatric Patients With CKD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06860711
2028-12
Study completion TaVNS for Acute Intracerebral Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06918964
2028-12
2028-12
Study completion Postpartum Evaluation of Nifedipine and Enalapril for Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07023003
2028-12
Study completion High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07059728
2028-12
Study completion TRicuspid Uk STudy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07133386
2028-12
Primary completion TRicuspid Uk STudy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07133386
2028-12
2028-12
2028-12
Study completion Minocycline in Stroke Study at Maimonides Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07237048
2028-12
Study completion Dronedarone Rhythm Intervention for Early Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07270848
2028-12
2028-12
2028-12
Study completion A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07318155
2028-12
Study completion Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07338175
2028-12
Primary completion OPTION-EMEA Clinical Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07349121
2028-12
Primary completion The Southern-Norway Post-Stroke Atrial Fibrillation Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07407790
2028-12
Study completion Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07475949
2028-12
Primary completion Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07475949
2028-12
2028-12
2028-12
2028-12
Study completion Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07583446
2028-12
Primary completion Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07583446
2028-12
2028-12
2028-12
2028-12
2028-12
Study completion GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07617155
2028-12
Study completion MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07632157
2028-12
Primary completion MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07632157
2028-12
2028-12
2028-12
2028-12
2028-12
2028-12
Primary completion Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07719894
2028-12
Study completion Systematic Ambulatory ECG Monitoring Following TAVI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07739316
2028-12
Primary completion Systematic Ambulatory ECG Monitoring Following TAVI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07739316
2028-12
Study completion Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07824323
2028-12
Study completion Post-Marketing Clinical Study of High-Pressure Cutting Balloon Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07835178
2028-12
Primary completion Post-Marketing Clinical Study of High-Pressure Cutting Balloon Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07835178
2028-12
2028-12
2028-12-04
2028-12-05
Study completion Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07866066
2028-12-06
Primary completion Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07066137
2028-12-07
2028-12-07
Primary completion A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07218029
2028-12-08
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2024-10-30
Study start Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke Registry record
Expected 2024-10-30; that period ended on 2024-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06645522
2024-10
Primary completion A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02785120
2024-10-31
Study completion The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis Registry record
Expected 2024-10-31; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03163329
2024-10-31
Study completion IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI Registry record
Expected 2024-10-31; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04797832
2024-10-31
Primary completion IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI Registry record
Expected 2024-10-31; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04797832
2024-10
Study completion IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04849325
2024-10
Primary completion Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04907123
2024-10-31
Study completion Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy Registry record
Expected 2024-10-31; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05326490
2024-10
Study completion Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05580068
2024-10
Primary completion Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05580068
2024-10
Primary completion EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05584319
2024-10
Primary completion Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05600387
2024-10
Primary completion Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06197022
2024-10-31
Study start Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation Registry record
Expected 2024-10-31; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06604611
2024-10
Study start Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy Registry record
Expected 2024-10; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06660940
2024-10-31
Study start The Androtriol Injection for the Treatment of Acute Ischemic Stroke Registry record
Expected 2024-10-31; that period ended on 2024-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06679322
2024-11-01
2024-11-01
Study start Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension Registry record
Expected 2024-11-01; that period ended on 2024-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06091176
2024-11-01
Primary completion Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates Registry record
Expected 2024-11-01; that period ended on 2024-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06256211
2024-11-01
Study start The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes Registry record
Expected 2024-11-01; that period ended on 2024-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06471699
2024-11-01
Study start Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus Registry record
Expected 2024-11-01; that period ended on 2024-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06616961
2024-11-01
Study completion the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients Registry record
Expected 2024-11-01; that period ended on 2024-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06653946
2024-11-11
Study completion A Study of Distal Jejunal-release Dextrose in Obese Participants Registry record
Expected 2024-11-11; that period ended on 2024-11-11.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05385978
2024-11-11
Primary completion A Study of Distal Jejunal-release Dextrose in Obese Participants Registry record
Expected 2024-11-11; that period ended on 2024-11-11.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05385978
2024-11-15
Study completion Effect of Dapagliflozin on VT in Patients With Heart Failure. Registry record
Expected 2024-11-15; that period ended on 2024-11-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05550441
2024-11-15
Primary completion Effect of Dapagliflozin on VT in Patients With Heart Failure. Registry record
Expected 2024-11-15; that period ended on 2024-11-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05550441
2024-11-20
Study start Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Registry record
Expected 2024-11-20; that period ended on 2024-11-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06587347
2024-11-20
Study start Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome Registry record
Expected 2024-11-20; that period ended on 2024-11-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06703788
2024-11-24
Primary completion Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes Registry record
Expected 2024-11-24; that period ended on 2024-11-24.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05950516
2024-11-28
Primary completion A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. Registry record
Expected 2024-11-28; that period ended on 2024-11-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05246410
2024-11-28
Primary completion Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window Registry record
Expected 2024-11-28; that period ended on 2024-11-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05634382
2024-11-30
Study completion Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism Registry record
Expected 2024-11-30; that period ended on 2024-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04088292
2024-11-30
Primary completion Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT Registry record
Expected 2024-11-30; that period ended on 2024-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04702373
2024-11-30
Study completion Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation Registry record
Expected 2024-11-30; that period ended on 2024-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05459974
2024-11-30
Primary completion Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO Registry record
Expected 2024-11-30; that period ended on 2024-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05577195
2024-11
2024-11
Primary completion EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Registry record
Expected 2024-11; that period ended on 2024-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06138834
2024-11
Study start Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention Registry record
Expected 2024-11; that period ended on 2024-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06682351
2024-12-01
Study completion Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03454724
2024-12-01
Study completion Diabetes Discharge Transitional CGM Study (DDT-CGM) Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04729985
2024-12-01
Study completion Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04853758
2024-12-01
Primary completion Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04853758
2024-12-01
Study completion Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05309460
2024-12-01
Primary completion Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05624203
2024-12-01
Primary completion Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05649488
2024-12-01
Study completion Safety and Efficacy of Evolocumab in Ischemic Stroke Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05697185
2024-12-01
Primary completion A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05783557
2024-12-01
Study completion Efficacy and Safety of Portable Hydrogen Rich Water Machine is Used for Adjuvant Treatment of Patients With Hyperlipidemia Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06301451
2024-12-01
Primary completion Efficacy and Safety of Portable Hydrogen Rich Water Machine is Used for Adjuvant Treatment of Patients With Hyperlipidemia Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06301451
2024-12-01
Study start Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome Registry record
Expected 2024-12-01; that period ended on 2024-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06723002
2024-12-10
Study start Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation Registry record
Expected 2024-12-10; that period ended on 2024-12-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06645249
2024-12-16
Study completion Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism Registry record
Expected 2024-12-16; that period ended on 2024-12-16.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06164379
2024-12-16
Primary completion Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism Registry record
Expected 2024-12-16; that period ended on 2024-12-16.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06164379
2024-12-20
Primary completion Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction Registry record
Expected 2024-12-20; that period ended on 2024-12-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05604976
2024-12-20
Primary completion Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA Registry record
Expected 2024-12-20; that period ended on 2024-12-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06196047
2024-12-29
Study completion Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification Registry record
Expected 2024-12-29; that period ended on 2024-12-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05539898
2024-12-30
Study completion Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04093336
2024-12-30
Primary completion Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04093336
2024-12-30
Study completion ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04476173
2024-12-30
Study completion Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04702373
2024-12-30
Primary completion Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04762472
2024-12-30
Study completion A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05246410
2024-12-30
Study completion Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05392712
2024-12-30
Primary completion Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis(Timing Trial) Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05574972
2024-12-30
Study completion Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05624203
2024-12-30
2024-12-30
Primary completion DCB Under the Guidance of OCT in STEMI Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05680051
2024-12-30
Study completion Validation of ECG Waveform and Arrhythmia Diagnosis Concordance for Pediatric Patients Using ECG Monitoring Patch Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05756309
2024-12-30
Primary completion Validation of ECG Waveform and Arrhythmia Diagnosis Concordance for Pediatric Patients Using ECG Monitoring Patch Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05756309
2024-12-30
Study completion Empagliflozin to Prevent Post-Operative Atrial Fibrillation Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06124937
2024-12-30
Primary completion Empagliflozin to Prevent Post-Operative Atrial Fibrillation Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06124937
2024-12-30
Study completion Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06196047
2024-12-30
Study completion Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06256211
2024-12-30
Primary completion Analysis of the Efficacy and Stability of a Wearable ECG Monitor Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06546046
2024-12-30
Study start QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension Registry record
Expected 2024-12-30; that period ended on 2024-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06716970
2024-12-31
Study completion Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01450722
2024-12-31
Primary completion Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective, Randomized Comparison With Bypass Surgery Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01450722
2024-12
Study completion Early Mobilization After Achilles Tendon Rupture Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02318472
2024-12-31
Primary completion Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02342444
2024-12
Study completion A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02785120
2024-12
Primary completion Controlling and Lowering Blood Pressure With the MobiusHD™ Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02827032
2024-12-31
Study completion Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02928094
2024-12
Study completion The Effect of Isokinetic Strengthening Training Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02938416
2024-12
Primary completion The Effect of Isokinetic Strengthening Training Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02938416
2024-12-31
Study completion Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03234114
2024-12-31
Primary completion Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03234114
2024-12-31
Primary completion Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03252626
2024-12
Study completion VitaFlowTM II Transcatheter Aortic Valve System Study Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03575039
2024-12-31
Study completion Metformin as RenoProtector of Progressive Kidney Disease Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03831464
2024-12-31
Primary completion Metformin as RenoProtector of Progressive Kidney Disease Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03831464
2024-12-31
Primary completion A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03998319
2024-12-31
Study completion Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04088513
2024-12-31
Primary completion Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04088513
2024-12-31
Primary completion Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04160000
2024-12-31
Primary completion Optimising Pacing for Contractility 2 Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04201015
2024-12-31
Study completion Use of Telemonitoring to Facilitate Heart Failure Medication Titration Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04205513
2024-12-31
Study completion A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04255602
2024-12-31
Primary completion A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04255602
2024-12
Study completion Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04258397
2024-12-31
Study completion Effects of Preferential Left Ventricular Pacing on Ventriculoarterial Coupling and Clinical Course of Heart Failure Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04420065